Changes in fecal short-chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome.

Magdy El-SalhyJørgen ValeurTrygve HauskenJan Gunnar Hatlebakk

Published in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2020)

FMT increases the fecal SCFA levels in IBS patients. The increase in the butyric acid level is inversely correlated with symptoms in IBS patients following FMT, suggesting that SCFAs might play a role in the pathophysiology of IBS. www.clinicaltrials.gov (NCT03822299).

Keyphrases

irritable bowel syndrome
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
stem cells
patient reported outcomes
depressive symptoms
patient reported
sleep quality